Patricia Louzon1,2, Heath Jennings3, Mahmood Ali4,5, Marijo Kraisinger3. 1. Critical Care and ED Pharmacy Division, Florida Hospital Orlando, Orlando, FL patricia.louzon@flhosp.org. 2. University of Florida College of Pharmacy, Gainesville, FL patricia.louzon@flhosp.org. 3. Florida Hospital Orlando, Orlando, FL. 4. Medical Intensive Care Unit, Florida Hospital Orlando, Orlando, FL. 5. Central Florida Pulmonary Group, Orlando, FL.
Abstract
PURPOSE: A two-phase program to increase pharmacist involvement in management of pain, agitation and delirium (PAD) at a large community teaching hospital is described. SUMMARY: Florida Orlando Hospital implemented a two-phase initiative to decrease intensive care unit (ICU) length of stay (LOS), ventilator use, sedative use, and hospital expenditures while advancing pharmacists' scope of practice. Phase 1 of the initiative involved a pilot project to evaluate pharmacist management of sedative therapy for mechanically ventilated patients. Using a newly developed PAD order set, a pharmacist performed daily sedation management in a cohort of patients; relative to physician-managed standard care, pharmacist-directed sedation management resulted in fewer hours of patient exposure to continuous sedation, with an overall 46% reduction in continuous infusions of sedatives and reductions in both ICU and total hospital LOS, resulting in estimated savings of $1.2 million in direct hospital costs and $183,216 in drug costs. In phase 2 of the project, an expanded group of pharmacists collaborated with interprofessional teams to manage PAD using an integrated "ABCDE bundle" to promote early mobility and weaning from sedatives and analgesics. A retrospective comparison of data on a cohort of medical ICU patients managed using the ABCDE bundle approach (n = 436) and a standard-care cohort (n = 499) demonstrated improvements in several outcomes, including mean ventilator days per patient, ICU LOS, and mortality. CONCLUSION: The provision of proactive critical care pharmacist services directed at PAD management is an innovative approach to fostering interprofessional collaboration and optimizing clinical outcomes.
PURPOSE: A two-phase program to increase pharmacist involvement in management of pain, agitation and delirium (PAD) at a large community teaching hospital is described. SUMMARY: Florida Orlando Hospital implemented a two-phase initiative to decrease intensive care unit (ICU) length of stay (LOS), ventilator use, sedative use, and hospital expenditures while advancing pharmacists' scope of practice. Phase 1 of the initiative involved a pilot project to evaluate pharmacist management of sedative therapy for mechanically ventilated patients. Using a newly developed PAD order set, a pharmacist performed daily sedation management in a cohort of patients; relative to physician-managed standard care, pharmacist-directed sedation management resulted in fewer hours of patient exposure to continuous sedation, with an overall 46% reduction in continuous infusions of sedatives and reductions in both ICU and total hospital LOS, resulting in estimated savings of $1.2 million in direct hospital costs and $183,216 in drug costs. In phase 2 of the project, an expanded group of pharmacists collaborated with interprofessional teams to manage PAD using an integrated "ABCDE bundle" to promote early mobility and weaning from sedatives and analgesics. A retrospective comparison of data on a cohort of medical ICU patients managed using the ABCDE bundle approach (n = 436) and a standard-care cohort (n = 499) demonstrated improvements in several outcomes, including mean ventilator days per patient, ICU LOS, and mortality. CONCLUSION: The provision of proactive critical care pharmacist services directed at PAD management is an innovative approach to fostering interprofessional collaboration and optimizing clinical outcomes.
Authors: Fabio da Silva Moraes; Lívia Luize Marengo; Mariana Del Grossi Moura; Cristiane de Cássia Bergamaschi; Fernando de Sá Del Fiol; Luciane Cruz Lopes; Marcus Tolentino Silva; Silvio Barberato-Filho Journal: Medicine (Baltimore) Date: 2022-06-24 Impact factor: 1.817
Authors: Amy Werremeyer; Jolene Bostwick; Carla Cobb; Tera D Moore; Susie H Park; Cristofer Price; Jerry McKee Journal: Ment Health Clin Date: 2020-11-05
Authors: Joanna L Stollings; Sarah L Bloom; Li Wang; E Wesley Ely; James C Jackson; Carla M Sevin Journal: Ann Pharmacother Date: 2018-02-18 Impact factor: 3.154
Authors: Antoinette B Coe; Rebecca E Bookstaver; Andrew C Fritschle; Michael T Kenes; Pamela MacTavish; Rima A Mohammad; Robert J Simonelli; Jessica A Whitten; Joanna L Stollings Journal: Hosp Pharm Date: 2019-01-28